Latest news

Malnutrition in healthcare: treatment pays off

Valuation of Innovative Drugs at ISPOR 2023 in Copenhagen

Integrated Valuation Model - V4A2M Model

Mark Nuijten EPA 2021

An innovative pricing model to assess the price of expensive drugs with an orphan indication

Lees meer

Innovation Premium for Innovative Orphan Drugs in Oncology and Rare Diseases

Guest lecture for Colombian American Chamber of Commerce on Pricing Policy for Orphan Drugs

Milestone of more than 10’000 views on our policy paper challenging the ICER

International Market Access Update

Economic impact of macrosomia

Increasing interest in our Pricing Model and Algorithm for "expensive" drugs